维信金科(02003)发布公告，于2025年9月16日，根据并依照第1号股份奖励计划的条款公司向集团2位雇 员授予22.5万股奖励股份的奖励(惟须待彼等接纳)，占于本公告日期已发行股份总数约0.05%。 ...

Core Viewpoint - Alibaba Health (00241) announced the grant of a total of 949,000 restricted stock units to 17 grantees under the 2024 share incentive plan, pending acceptance for it to take effect [1] Summary by Category - **Company Announcement** - The company will grant 949,000 restricted stock units to 17 individuals as part of its incentive plan [1]

Core Viewpoint - Alibaba Health (00241.HK) has granted a total of 950,000 restricted share units to 17 recipients under the 2024 Share Award Plan, pending acceptance, aimed at promoting the company's development and expansion [1] Group 1: Purpose of Granting Restricted Share Units - The purpose of granting restricted share units includes providing opportunities for individuals with skills and experience to acquire equity in the company, thereby attracting them to facilitate further development and expansion of the group [1] - It also serves to recognize the contributions of existing employees to the success and development of the group [1] - Additionally, the grant aims to fully incentivize and motivate employees to remain with the group, promoting future growth and expansion [1]

Group 1 - The company announced a share award plan adopted at the annual general meeting held on May 30, 2025 [1] - A total of 9.915 million shares will be granted to 197 eligible participants, including directors and employees of the group [1] - The grant of shares is subject to acceptance by the participants [1]

Group 1 - The core point of the article is that China Xuyang Group has announced a share award plan to grant a total of 9.915 million shares to 197 eligible participants, including directors and employees, as part of its strategy to attract, retain, and incentivize talent [1] - The share award plan was adopted during the company's annual general meeting held on May 30, 2025 [1] - The purpose of granting these shares is to encourage participants to enhance the value of the company and its shares for the benefit of the company and its shareholders [1]

Core Viewpoint - The company has adopted a share award plan effective September 1, 2025, which does not require shareholder approval as it involves existing shares only [1]. Group 1 - The share award plan is in accordance with Listing Rule 17.01(1)(b) and is classified under Chapter 17 of the Listing Rules [1]. - The plan will be funded by existing shares, thus it does not involve the issuance of new shares as per Listing Rule 17.01(1)(a) [1]. - The company must comply with the disclosure requirements under Listing Rule 17.12 related to this plan [1].

Core Viewpoint - China Liansu (02128) announced the termination of its share incentive plan due to the expectation of not granting shares before the plan's expiration and to reduce administrative costs [1] Summary by Relevant Sections - **Incentive Plan Status** - No shares have been granted under the incentive plan since its adoption [1] - The board has decided to terminate the plan effective August 31, 2025 [1] - **Impact of Termination** - The termination will not affect any existing rights of selected participants as there are currently no selected participants [1] - The board believes that the termination will not have any significant adverse impact on the company and is in the best interest of the company and its shareholders [1]

Core Viewpoint - Yunfeng Financial (00376) announced the proposal to adopt a new share award plan for 2025, which will replace the existing 2016 share award plan set to expire in December 2026, pending shareholder approval [1] Group 1: 2025 Share Award Plan - The 2025 Share Award Plan is designed to encourage eligible participants, including employees and service providers, to hold shares and align their interests with those of shareholders [1] - The plan aims to retain key contributors to the group and provide additional rewards for achieving performance targets, thereby enhancing the company's value [1] Group 2: Amendments to Existing Plans - The board proposes to amend the 2022 Share Option Plan to comply with revised listing rules, allowing the use of the company's treasury shares for option settlements [1] - The amendments will also reflect internal management adjustments and other corresponding revisions [1]

Core Viewpoint - Yunfeng Financial (00376) announced the proposal to adopt a new share award plan for 2025, which will replace the existing 2016 share award plan set to expire in December 2026, pending shareholder approval [1] Group 1: Share Award Plans - The 2025 Share Award Plan is designed to encourage eligible participants, including employees and service providers, to hold shares and align their interests with those of shareholders [1] - The board also proposed amendments to the 2022 Share Option Plan to ensure compliance with revised listing rules, allowing the use of the company's treasury shares for option settlements [1]

Group 1 - The company, Tengsheng Bo Pharmaceutical-B (02137), announced the issuance and allocation of 130,800 shares to employees as part of its restricted share unit plan adopted on June 22, 2021 [1]